What is Global Platelet-rich Plasma Therapy Market?
The Global Platelet-rich Plasma Therapy Market is a rapidly expanding sector within the healthcare industry. This market focuses on the use of platelet-rich plasma (PRP), a component of blood that has been concentrated to contain a higher number of platelets. PRP is believed to promote healing and regeneration in various medical and cosmetic procedures, due to its rich content of growth factors and cytokines. The therapy is used in a wide range of applications, from orthopedic and sports injuries to aesthetic and anti-aging treatments. The market's growth is driven by the increasing prevalence of musculoskeletal disorders, the rising number of sports injuries, and the growing use of PRP in various therapeutic areas. Furthermore, advancements in PRP extraction technologies and the increasing awareness about PRP therapy's benefits are also contributing to the market's expansion.
Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF) in the Global Platelet-rich Plasma Therapy Market:
The Global Platelet-rich Plasma Therapy Market is segmented into Pure PRP, Leucocyte-rich PRP, and Leukocyte-rich Fibrin (L-PRF). Pure PRP is platelet-rich plasma without leukocytes. It is often used in aesthetic procedures, such as facial rejuvenation and hair loss treatment, due to its high concentration of growth factors. Leucocyte-rich PRP, on the other hand, contains both platelets and leukocytes. It is commonly used in orthopedic and sports medicine for its anti-inflammatory and antimicrobial properties. Lastly, Leukocyte-rich Fibrin (L-PRF) is a second-generation PRP product. It is a solid fibrin matrix in which platelets and leukocytes are embedded. L-PRF is used in dental and maxillofacial surgery for its superior healing properties.
Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Others in the Global Platelet-rich Plasma Therapy Market:
The Global Platelet-rich Plasma Therapy Market finds its application in various areas such as Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury, among others. In Orthopedics, PRP is used to treat conditions like osteoarthritis and tendon injuries. In Dermatology, it is used for skin rejuvenation and hair loss treatment. PRP therapy is also used in Cardiac Muscle Injury for its potential to improve heart function after a heart attack. In Dental procedures, PRP is used to promote faster healing and bone regeneration. In case of Nerve Injury, PRP therapy is believed to promote nerve regeneration. Other applications of PRP therapy include treatment of chronic wounds and sports injuries.
Global Platelet-rich Plasma Therapy Market Outlook:
The market outlook for the Global Platelet-rich Plasma Therapy Market is promising. In 2023, the market was valued at US$ 722 million and is expected to reach US$ 1919.8 million by 2030, growing at a CAGR of 15.0% during the forecast period 2024-2030. This growth is significantly higher than the global pharmaceutical market, which is projected to grow at a CAGR of 5% over the next six years, reaching 1475 billion USD in 2022. The chemical drug market, on the other hand, is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The rapid growth of the PRP therapy market can be attributed to its wide range of applications, the increasing prevalence of conditions that can be treated with PRP, and the growing awareness about the benefits of PRP therapy.
Report Metric | Details |
Report Name | Platelet-rich Plasma Therapy Market |
Accounted market size in 2023 | US$ 722 million |
Forecasted market size in 2030 | US$ 1919.8 million |
CAGR | 15.0% |
Base Year | 2023 |
Forecasted years | 2024 - 2030 |
Segment by Type |
|
Segment by Application |
|
By Region |
|
By Company | Terumo, Arthrex, Zimmer Biomet, J & J, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics |
Forecast units | USD million in value |
Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |